We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current EMD market cap is 19.06M. The company's latest EPS is AUD -0.0140 and P/E is -3.57.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 110k | 1.48M | 2.93M | 3.09M | 3.8M |
| Operating Income | -2.7M | -5.2M | -4.86M | -7.27M | -4.9M |
| Net Income | -2.68M | -5.24M | -4.91M | -7.33M | -5.13M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 3.53M | 5.07M | 9.06M | 8.25M | 10.16M |
| Total Liabilities | 3.03M | 1.28M | 1.88M | 1.93M | 3.37M |
| Total Equity | 500k | 3.78M | 7.18M | 6.32M | 6.79M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -2.6M | -4.45M | -3.94M | -5.43M | -3.77M |
| Investing | -901k | -202k | -661k | -2.03M | -3.23M |
| Financing | 3.06M | 5.73M | 7.44M | 4.81M | 5.86M |
| Market Cap | 19.06M |
| Price to Earnings Ratio | -3.57 |
| Price to Sales Ratio | 4.81 |
| Price to Cash Ratio | 6.67 |
| Price to Book Ratio | 2.7 |
| Dividend Yield | - |
| Shares Outstanding | 366.63M |
| Average Volume (1 week) | 473.04k |
| Average Volume (1 Month) | 284.02k |
| 52 Week Change | -61.48% |
| 52 Week High | 0.145 |
| 52 Week Low | 0.041 |
| Spread (Intraday) | 0 (3.85%) |
| Company Name | Emyria Limited |
| Address |
d2 661 newcastle street perth, western australia 6007 |
| Website | https://www.emeraldclinics.com.au |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
